This information is current as Striking Antiviral Potential Allows Induction of CD8 T Cells That Have a from Multispecific DNA-Based Vaccines Elimination of Immunodominant Epitopes

[1]  L. Frelin,et al.  A Mechanism To Explain the Selection of the Hepatitis e Antigen-Negative Mutant during Chronic Hepatitis B Virus Infection , 2008, Journal of Virology.

[2]  S. Kochanek,et al.  The immunogenicity of adenovirus vectors limits the multispecificity of CD8 T-cell responses to vector-encoded transgenic antigens. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[3]  S. Kochanek,et al.  Recombinant complexes of antigen with stress proteins are potent CD8 T-cell-stimulating immunogens , 2008, Journal of Molecular Medicine.

[4]  K. Reifenberg,et al.  Transgenic mice replicating hepatitis B virus but lacking expression of the major HBsAg , 2008, Journal of medical virology.

[5]  Alessandro Sette,et al.  Rational Design of a Multiepitope Vaccine Encoding T-Lymphocyte Epitopes for Treatment of Chronic Hepatitis B Virus Infections , 2007, Journal of Virology.

[6]  B. Graham,et al.  Relative dominance of epitope-specific CD8+ T cell responses in an F1 hybrid mouse model of respiratory syncytial virus infection. , 2007, Virology.

[7]  G. Freeman,et al.  PD-1:PD-L1 Interactions Contribute to the Functional Suppression of Virus-Specific CD8+ T Lymphocytes in the Liver1 , 2007, The Journal of Immunology.

[8]  P. Marrack,et al.  CD8 T cell competition for dendritic cells in vivo is an early event in activation , 2006, Proceedings of the National Academy of Sciences.

[9]  M. Bevan,et al.  T cells with low avidity for a tissue-restricted antigen routinely evade central and peripheral tolerance and cause autoimmunity. , 2006, Immunity.

[10]  Antonio Bertoletti,et al.  The immune response during hepatitis B virus infection. , 2006, The Journal of general virology.

[11]  R. Webby,et al.  A virus-specific CD8+ T cell immunodominance hierarchy determined by antigen dose and precursor frequencies. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Migueles,et al.  Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses , 2005, The Journal of experimental medicine.

[13]  F. Chisari,et al.  Stealth and Cunning: Hepatitis B and Hepatitis C Viruses , 2005, Journal of Virology.

[14]  E. Sercarz,et al.  Understanding crypticity is the key to revealing the pathogenesis of autoimmunity. , 2005, Trends in immunology.

[15]  A. Rosato,et al.  A Large Number of T Lymphocytes Recognize Moloney-Murine Leukemia Virus-Induced Antigens, but a Few Mediate Long-Lasting Tumor Immunosurveillance 1 , 2005, The Journal of Immunology.

[16]  P. Schirmacher,et al.  Liver-specific expression of interferon γ following adenoviral gene transfer controls hepatitis B virus replication in mice , 2005, Gene Therapy.

[17]  D. Tscharke,et al.  Regulatory T Cells Suppress CD8+ T Cell Responses Induced by Direct Priming and Cross-Priming and Moderate Immunodominance Disparities , 2005, The Journal of Immunology.

[18]  F. Chisari,et al.  Immune Tolerance Split between Hepatitis B Virus Precore and Core Proteins , 2005, Journal of Virology.

[19]  B. Rehermann,et al.  Immunology of hepatitis B virus and hepatitis C virus infection , 2005, Nature Reviews Immunology.

[20]  J. Reimann,et al.  DNA vaccines prime CD8+ T cell responses to epitopes of viral antigens produced from overlapping reading frames of a single coding sequence , 2005, European journal of immunology.

[21]  Marcus Groettrup,et al.  Immunoproteasomes Down-Regulate Presentation of a Subdominant T Cell Epitope from Lymphocytic Choriomeningitis Virus1 , 2004, The Journal of Immunology.

[22]  Geoffrey Dusheiko,et al.  Longitudinal Analysis of CD8+ T Cells Specific for Structural and Nonstructural Hepatitis B Virus Proteins in Patients with Chronic Hepatitis B: Implications for Immunotherapy , 2004, Journal of Virology.

[23]  Michael Basler,et al.  Immunodominance of an Antiviral Cytotoxic T Cell Response Is Shaped by the Kinetics of Viral Protein Expression1 , 2003, The Journal of Immunology.

[24]  P. Neuhaus,et al.  Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B‐related disease , 2003, Hepatology.

[25]  Paul Chaplin,et al.  Enhanced Priming of Multispecific, Murine CD8+ T Cell Responses by DNA Vaccines Expressing Stress Protein-Binding Polytope Peptides1 , 2003, The Journal of Immunology.

[26]  Philippa Marrack,et al.  Epitope dominance, competition and T cell affinity maturation. , 2003, Current opinion in immunology.

[27]  P. Schultz,et al.  Searching for Interferon-Induced Genes That Inhibit Hepatitis B Virus Replication in Transgenic Mouse Hepatocytes , 2003, Journal of Virology.

[28]  K. Gould,et al.  Competition Between MHC Class I Alleles for Cell Surface Expression Alters CTL Responses to Influenza A Virus1 , 2002, The Journal of Immunology.

[29]  Eun Young Choi,et al.  Immunodominance of H60 is caused by an abnormally high precursor T cell pool directed against its unique minor histocompatibility antigen peptide. , 2002, Immunity.

[30]  J. Trojan,et al.  Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers. , 2002, Vaccine.

[31]  J. Reimann,et al.  Priming polyvalent immunity by DNA vaccines expressing chimeric antigens with a stress protein‐capturing, viral J‐domain , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  J. Reimann,et al.  The Immunodominant, Ld-Restricted T Cell Response to Hepatitis B Surface Antigen (HBsAg) Efficiently Suppresses T Cell Priming to Multiple Dd-, Kd-, and Kb-Restricted HBsAg Epitopes1 , 2002, The Journal of Immunology.

[33]  J. Reimann,et al.  Noncovalent Association with Stress Protein Facilitates Cross-Priming of CD8+ T Cells to Tumor Cell Antigens by Dendritic Cells1 , 2002, The Journal of Immunology.

[34]  C. Bréchot,et al.  Efficacy and limitations of a specific immunotherapy in chronic hepatitis B. , 2001, Journal of hepatology.

[35]  G. Ogg,et al.  Lamivudine treatment can overcome cytotoxic T‐cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy , 2001, Hepatology.

[36]  D. Vergani,et al.  Incubation phase of acute hepatitis B in man: Dynamic of cellular immune mechanisms , 2000, Hepatology.

[37]  Antonio Bertoletti,et al.  The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. , 2000 .

[38]  D. Vergani,et al.  The Role of Virus-Specific Cd8+ Cells in Liver Damage and Viral Control during Persistent Hepatitis B Virus Infection , 2000, The Journal of experimental medicine.

[39]  D. Vergani,et al.  Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection. , 1999, Gastroenterology.

[40]  J. Reimann,et al.  Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent. , 1999, Journal of immunology.

[41]  A. Sette,et al.  Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans. , 1999, Journal of immunology.

[42]  G. Gerken,et al.  The presence of high amounts of HBV-DNA in serum is associated with suppressed costimulatory effects of interleukin 12 on HBV-induced immune response. , 1999, Journal of hepatology.

[43]  A. Bertoletti,et al.  Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. , 1998, The Journal of clinical investigation.

[44]  P. Grufman,et al.  Superdominance among immunodominant H-2Kb-restricted epitopes and reversal by dendritic cell-mediated antigen delivery. , 1998, Journal of immunology.

[45]  R W Chesnut,et al.  Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. , 1997, The Journal of clinical investigation.

[46]  F. Lemonnier,et al.  HLA-A2.1–restricted Education and Cytolytic Activity of CD8+ T Lymphocytes from β2 Microglobulin (β2m) HLA-A2.1 Monochain Transgenic H-2Db β2m Double Knockout Mice , 1997, The Journal of experimental medicine.

[47]  F. Chisari,et al.  To kill or to cure: options in host defense against viral infection. , 1996, Current opinion in immunology.

[48]  F. Chisari,et al.  DNA immunization induces antibody and cytotoxic T cell responses to hepatitis B core antigen in H-2b mice. , 1996, Journal of immunology.

[49]  F. Chisari,et al.  High-level hepatitis B virus replication in transgenic mice , 1995, Journal of virology.

[50]  B. Moss,et al.  The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis , 1995, The Journal of experimental medicine.

[51]  A. Vitiello,et al.  The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. , 1994, Journal of immunology.

[52]  F. Chisari,et al.  Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[53]  R. Palmiter,et al.  Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. , 1990, Science.

[54]  R. Palmiter,et al.  Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice , 1989, Cell.

[55]  R. Palmiter,et al.  A transgenic mouse model of the chronic hepatitis B surface antigen carrier state. , 1985, Science.

[56]  Antonio Polley,et al.  Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection , 2009, Nature Immunology.

[57]  H. Hauser,et al.  Antigen Protein-Capturing Tumor-Associated DNA Vaccines Encoding Chimeric , Stress Priming Protective CD 8 T Cell Immunity by Kröger and Jörg Reimann , 2006 .

[58]  Hans-Georg Rammensee,et al.  MHC ligands and peptide motifs: first listing , 2004, Immunogenetics.

[59]  D. Stober,et al.  The Immunodominant, L-Restricted T Cell Response to Hepatitis B Surface Antigen (HBsAg) Efficiently Suppresses T Cell Priming to Multiple D-, K-, and K-Restricted HBsAg Epitopes , 2002 .

[60]  W Chen,et al.  Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. , 2000, Immunity.

[61]  J. Yewdell,et al.  Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. , 1999, Annual review of immunology.

[62]  K. Reifenberg,et al.  Long-term expression of the hepatitis B virus core-e- and X-proteins does not cause pathologic changes in transgenic mice. , 1997, Journal of hepatology.

[63]  F. Chisari,et al.  Hepatitis B virus immunopathogenesis. , 1995, Annual review of immunology.

[64]  J. Sung,et al.  Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion. , 1992, The Journal of clinical investigation.